Cipla Sustainability

Sustainability

Our approach to responsible resource consumption, efforts to enhance access and affordability of medicines worldwide and strong financial growth, provide a robust foundation to build a responsible business.

Sustainability Goals 2030

By 2025

Cipla endeavours to be a Carbon Neutral, Water Neutral and Zero Waste to Landfill Company

By 2030

Cipla endeavours to be a Carbon Positive, Water Positive and AMR Compliant Company
9% Revenue CAGR over the last 5years
6.9% R&D Investment
₹ 17,132 Crores Revenue from Operations

Manufacturing Highlights

Our investments in manufacturing capital include development of new drug delivery systems, facilitation of infrastructure supporting API and formulation developments and strengthening of platform technologies.

Building a healthy world

46
state-of-the-art manufacturing facilitiesacross 5 countries

Fighting global diseases

50+
dosage forms 1,500+ products

Employees

26,000+
global
employees

R&D

1,300+
scientists and6 R&D facilities

Relationships

4 Lakh+
healthcare professionals3.5 lakh+ pharmacists

 

 

COMMITTEES
OF BOARD
Learn More
MILESTONE
AWARDS
Learn More